Position in LGND
as of Mar 31, 2026
· filed Apr 21, 2026
Position Value
$598
+$220 QoQ
Shares Held
3
+50.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 0.ToString("F0")%
None 100.ToString("F0")%
Common Shares in LGND Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026GILPIN WEALTH MANAGEMENT, LLC holds $134,544 across 18 Biotechnology names. LGND ranks #7 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | OTLK |
Outlook Therapeutics, Inc.
|
600,162 | $123,633 | |
| 2 | NTLA |
Intellia Therapeutics, Inc.
|
302 | $3,871 | |
| 3 | KRYS |
Krystal Biotech, Inc.
|
4 | $1,033 | |
| 4 | PTCT |
Ptc Therapeutics, Inc.
|
14 | $953 | |
| 5 | PTGX |
Protagonist Therapeutics, Inc
|
9 | $948 | |
| 6 | TGTX |
Tg Therapeutics, Inc.
|
23 | $764 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
This page
|
3 | $598 | |
| 8 | CPRX |
Catalyst Pharmaceuticals, Inc.
|
23 | $569 |
All Filings in LGND
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $598 | 3 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $378 | 2 | Shares | Sole | 2026-02-11 | |
| No filing history on record for this holder in this stock. | ||||||